NO965448L - Farmasöytiske forbindelser - Google Patents

Farmasöytiske forbindelser

Info

Publication number: NO965448L
Authority: NO; Norway
Prior art keywords: pharmaceutical compounds; pharmaceutical; compounds
Prior art date: 1995-12-19

Application number

NO965448A

Other languages

English (en)

Other versions

NO965448D0 (no

NO307512B1 (no

Inventor

Peter Thaddeus Gallagher

William Martin Owton

Colin William Smith

Original Assignee

Lilly Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-19

Filing date

1996-12-18

Publication date

1997-06-20

1996-12-18 Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd

1996-12-18 Publication of NO965448D0 publication Critical patent/NO965448D0/no

1997-06-20 Publication of NO965448L publication Critical patent/NO965448L/no

2000-04-17 Publication of NO307512B1 publication Critical patent/NO307512B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Indole Compounds (AREA)

NO965448A 1995-12-19 1996-12-18 Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse NO307512B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9525963A GB2308362A (en)	1995-12-19	1995-12-19	Pharmaceutical indole derivatives

Publications (3)

Publication Number	Publication Date
NO965448D0 NO965448D0 (no)	1996-12-18
NO965448L true NO965448L (no)	1997-06-20
NO307512B1 NO307512B1 (no)	2000-04-17

Family

ID=10785702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO965448A NO307512B1 (no)	1995-12-19	1996-12-18	Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse

Country Status (27)

Country	Link
US (1)	US5773448A (no)
EP (1)	EP0780388B1 (no)
JP (1)	JPH09202784A (no)
KR (1)	KR970042503A (no)
CN (1)	CN1157822A (no)
AR (1)	AR010205A1 (no)
AT (1)	ATE204273T1 (no)
AU (1)	AU720711B2 (no)
BR (1)	BR9606066A (no)
CA (1)	CA2193039C (no)
CZ (1)	CZ372296A3 (no)
DE (1)	DE69614491T2 (no)
DK (1)	DK0780388T3 (no)
ES (1)	ES2159693T3 (no)
GB (1)	GB2308362A (no)
HU (1)	HUP9603498A3 (no)
IL (1)	IL119844A (no)
MX (1)	MX9606531A (no)
NO (1)	NO307512B1 (no)
NZ (1)	NZ299959A (no)
PE (1)	PE26198A1 (no)
PL (1)	PL317526A1 (no)
PT (1)	PT780388E (no)
SG (1)	SG47206A1 (no)
TR (1)	TR199601018A1 (no)
YU (1)	YU67096A (no)
ZA (1)	ZA9610589B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9810886D0 (en) *	1998-05-13	1998-07-22	Lilly Industries Ltd	Pharmaceutical compounds
GB2362826A (en) *	2000-06-02	2001-12-05	Lilly Co Eli	A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US9119832B2 (en)	2014-02-05	2015-09-01	The Regents Of The University Of California	Methods of treating mild brain injury
US20170121385A1 (en)	2015-10-28	2017-05-04	Oxeia Biopharmaceuticals, Inc.	Methods of treating neurodegenerative conditions
CN106928122A (zh) *	2017-03-07	2017-07-07	贵州大学	3‑烷氧基季碳氧化吲哚及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4411890A (en) *	1981-04-14	1983-10-25	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
US4035369A (en) *	1975-10-08	1977-07-12	Janssen Pharmaceutica N.V.	1-Benzazolylalkyl-4-substituted-piperidines
US4432978A (en) *	1979-07-30	1984-02-21	Pfizer Inc.	Hexahydro-trans-pyridoindole
US4254127A (en) *	1980-04-03	1981-03-03	Janssen Pharmaceutica, N.V.	1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
FR2523964B1 (fr) *	1982-03-23	1985-09-27	Sanofi Sa	Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation
IL69132A (en) *	1982-07-14	1986-02-28	Roussel Uclaf	Benzo-and naphtho-thiopyranopyrimidinones,their preparation and pharmaceutical compositions containing them
US4658038A (en) *	1982-10-07	1987-04-14	Research Foundation For Mental Hygiene, Inc.	N-acylated 5-hydroxytryptophan amide derivatives
US4608374A (en) *	1983-11-07	1986-08-26	Hoechst-Roussel Pharmaceuticals Inc.	11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents
GB8332704D0 (en) *	1983-12-07	1984-01-11	Pfizer Ltd	Growth promotants for animals
EP0181793B1 (fr) *	1984-10-16	1988-07-27	Synthelabo	Dérivés de pipéridine, leur préparation et leur application en thérapeutique
US4789676A (en) *	1986-03-05	1988-12-06	Merrell Dow Pharmaceuticals Inc.	Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives, usefull as anxiolytic agents
FR2634207B1 (fr) *	1988-07-12	1990-09-07	Synthelabo	Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
EP0351283A1 (fr) *	1988-07-12	1990-01-17	Synthelabo	Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique
FR2635524B1 (fr) *	1988-08-19	1992-04-24	Adir	Nouveaux derives de benzopyrrolidinone, leur procede de preparation et les compositions pharmaceutiques les renfermant
US5068234A (en) *	1990-02-26	1991-11-26	Sterling Drug Inc.	3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9005014D0 (en) *	1990-03-06	1990-05-02	Janssen Pharmaceutica Nv	N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
TW203049B (no) *	1990-04-13	1993-04-01	Yamanouchi Pharma Co Ltd
FR2661177A1 (fr) *	1990-04-23	1991-10-25	Rhone Poulenc Sante	Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5328920A (en) *	1991-04-17	1994-07-12	Hoechst-Roussel Pharmaceuticals Incorporated	Substituted (pyridinylamino)-indoles
FR2679561A1 (fr) *	1991-07-26	1993-01-29	Schneider Marc	Nouveaux derives de l'(indolyl-1) alkylamine substituee par une chaine presentant des groupements carbonyles conjugues a un noyau aromatique.
SE9103752D0 (sv)	1991-12-18	1991-12-18	Astra Ab	New compounds
TW218875B (no) *	1992-03-09	1994-01-11	Takeda Pharm Industry Co Ltd
CA2092112A1 (en) *	1992-03-23	1993-09-24	Nobuyoshi Iwata	Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
EP0572235A3 (en) *	1992-05-28	1994-06-01	Tanabe Seiyaku Co	Beta-carboline derivatives with anticholecystoquinine activity
JPH08503213A (ja) *	1992-11-06	1996-04-09	メルクエンドカンパニーインコーポレーテッド	成長ホルモンの放出を促進する置換ジペプチド同族体
WO1994013696A1 (en) *	1992-12-11	1994-06-23	Merck & Co., Inc.	Spiro piperidines and homologs which promote release of growth hormone
US5536716A (en) *	1992-12-11	1996-07-16	Merck & Co., Inc.	Spiro piperidines and homologs which promote release of growth hormone
PL181280B1 (pl) *	1993-12-23	2001-07-31	Novo Nordisk As	oraz zawierajaca je kompozycja farmaceutyczna PL PL PL PL PL PL PL PL
DE69427650T2 (de) *	1993-12-23	2001-11-22	Novo Nordisk A/S, Bagsvaerd	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
GB9418326D0 (en) *	1994-09-12	1994-11-02	Lilly Industries Ltd	Pharmaceutical compounds
DE69531476T2 (de) *	1994-09-12	2004-06-09	Lilly Industries Ltd., Basingstoke	Serotonergische Modulatoren
US5798337A (en) *	1994-11-16	1998-08-25	Genentech, Inc.	Low molecular weight peptidomimetic growth hormone secretagogues

1995
- 1995-12-19 GB GB9525963A patent/GB2308362A/en not_active Withdrawn
1996
- 1996-12-16 CA CA002193039A patent/CA2193039C/en not_active Expired - Fee Related
- 1996-12-16 PE PE1996000916A patent/PE26198A1/es not_active Application Discontinuation
- 1996-12-17 PL PL96317526A patent/PL317526A1/xx unknown
- 1996-12-17 ZA ZA9610589A patent/ZA9610589B/xx unknown
- 1996-12-17 MX MX9606531A patent/MX9606531A/es unknown
- 1996-12-17 DE DE69614491T patent/DE69614491T2/de not_active Expired - Fee Related
- 1996-12-17 TR TR96/01018A patent/TR199601018A1/xx unknown
- 1996-12-17 AR ARP960105722A patent/AR010205A1/es not_active Application Discontinuation
- 1996-12-17 ES ES96309200T patent/ES2159693T3/es not_active Expired - Lifetime
- 1996-12-17 SG SG1996011771A patent/SG47206A1/en unknown
- 1996-12-17 PT PT96309200T patent/PT780388E/pt unknown
- 1996-12-17 DK DK96309200T patent/DK0780388T3/da active
- 1996-12-17 YU YU67096A patent/YU67096A/sh unknown
- 1996-12-17 EP EP96309200A patent/EP0780388B1/en not_active Expired - Lifetime
- 1996-12-17 AT AT96309200T patent/ATE204273T1/de not_active IP Right Cessation
- 1996-12-17 NZ NZ299959A patent/NZ299959A/en unknown
- 1996-12-17 IL IL11984496A patent/IL119844A/xx not_active IP Right Cessation
- 1996-12-18 BR BR9606066A patent/BR9606066A/pt not_active Application Discontinuation
- 1996-12-18 KR KR1019960067182A patent/KR970042503A/ko not_active Application Discontinuation
- 1996-12-18 NO NO965448A patent/NO307512B1/no not_active IP Right Cessation
- 1996-12-18 CN CN96117941A patent/CN1157822A/zh active Pending
- 1996-12-18 JP JP8337819A patent/JPH09202784A/ja active Pending
- 1996-12-18 CZ CZ963722A patent/CZ372296A3/cs unknown
- 1996-12-18 HU HU9603498A patent/HUP9603498A3/hu unknown
- 1996-12-19 AU AU75460/96A patent/AU720711B2/en not_active Ceased
1997
- 1997-04-14 US US08/833,239 patent/US5773448A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
MX9606531A (es)	1997-06-28
HU9603498D0 (en)	1997-02-28
GB2308362A (en)	1997-06-25
US5773448A (en)	1998-06-30
CA2193039A1 (en)	1997-06-20
PT780388E (pt)	2001-12-28
AU720711B2 (en)	2000-06-08
CN1157822A (zh)	1997-08-27
AR010205A1 (es)	2000-06-07
CZ372296A3 (en)	1997-08-13
PE26198A1 (es)	1998-05-27
TR199601018A1 (tr)	1997-07-21
JPH09202784A (ja)	1997-08-05
EP0780388B1 (en)	2001-08-16
DE69614491T2 (de)	2002-04-18
HUP9603498A2 (hu)	1998-09-28
YU67096A (sh)	1999-03-04
DE69614491D1 (de)	2001-09-20
CA2193039C (en)	2006-04-04
KR970042503A (ko)	1997-07-24
AU7546096A (en)	1997-06-26
EP0780388A1 (en)	1997-06-25
SG47206A1 (en)	1998-03-20
IL119844A0 (en)	1997-03-18
HUP9603498A3 (en)	2001-04-28
ES2159693T3 (es)	2001-10-16
ATE204273T1 (de)	2001-09-15
DK0780388T3 (da)	2001-10-08
NO965448D0 (no)	1996-12-18
IL119844A (en)	2000-12-06
NO307512B1 (no)	2000-04-17
ZA9610589B (en)	1998-01-16
GB9525963D0 (en)	1996-02-21
NZ299959A (en)	1998-09-24
PL317526A1 (en)	1997-06-23
BR9606066A (pt)	1998-09-01

Publication	Publication Date	Title
NO20004345L (no)	1996-12-23	Farmasøytisk sammensetning
ID16345A (id)	1997-09-25	Senyawa-senyawa heterosiklik
PT858325E (pt)	2002-12-31	Formulacao farmaceutica liofilizada estavel
FI973518A (fi)	1997-08-27	Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
IS4706A (is)	1998-03-31	Lyfjasamsetningar
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9607097A (pt)	1997-11-11	Novos compostos
DK0861235T3 (da)	2001-12-27	Substituerede benzylaminopiperidinforbindelser
DK0783302T3 (da)	2000-05-29	Lægemidler
FI960519A0 (fi)	1996-02-05	Uusia yhdisteitä
NO981008D0 (no)	1998-03-06	Farmasöytisk formulering
BR9610214A (pt)	1999-06-15	Compostos farmacéuticos
IS4739A (is)	1998-05-12	Efnasambönd
BR9600809A (pt)	1997-12-23	Medicamento
BR9607626A (pt)	1999-06-01	Novos compostos farmacéuticos de naftila
LV11727A (lv)	1997-04-20	Farmaceitiska kompozicija
NO974170D0 (no)	1997-09-09	Polyazacykloalkan-forbindelser
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
PT850048E (pt)	2004-09-30	Granulos farmaceuticos
FI973230A (fi)	1997-08-05	Uusi farmaseuttinen formulaatio
NO965448D0 (no)	1996-12-18	Farmasöytiske forbindelser
DE59610423D1 (de)	2003-06-12	Partikulare arzneiform
BR9605777A (pt)	1998-08-25	Composição farmacêutica
BR9605131A (pt)	1998-07-07	Composição farmacêutica
NO962816D0 (no)	1996-07-03	Farmasöytiske forbindelser

Legal Events

Date	Code	Title	Description
2002-08-05	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JUNE 2002